Toshiba to sponsor new 64-slice CT study in diabetics

Toshiba America Medical Systems of Tustin, CA, has launched a new clinical study designed to assess the utility of 64-slice CT for screening high-risk diabetic patients for coronary artery disease.

Called faCTor64, the study is designed as a follow-up to the CorE 64 trial that the company is sponsoring. The faCTor64 research is taking place across seven countries, comparing the use of CT as the primary diagnostic tool for detecting cardiovascular diseases and disorders compared to cardiac catheterization.

The study will be performed in conjunction with Intermountain Healthcare, a community-owned system of nonprofit hospitals and clinics based in Salt Lake City. More than 1,000 patients from Utah, women older than 55 years old and men older than 50 years old, will be enrolled in the faCTor64 study using Intermountain Healthcare's diabetes registry of 30,000 patients.

The faCTor64 study will use Toshiba's Aquilion 64-slice CT system to capture obstructive and nonobstructive, or subclinical, coronary heart disease data to determine the best way to treat diabetic patients.

By staff writers
November 6, 2007

Related Reading

Road to RSNA, Toshiba America Medical Systems, November 5, 2007

64-slice MDCT highly accurate for stenosis detection, November 5, 2007

Road to RSNA, Toshiba America Medical Systems, October 29, 2007

Toshiba completes first U.S. Infinix CF-i/SP install, October 23, 2007

Road to RSNA, Toshiba America Medical Systems, October 23, 2007

Copyright © 2007

Page 1 of 655
Next Page